Returns On Capital At Sysmex (TSE:6869) Have Stalled
Jan 21
Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Healthcare Sector Analysis
UpdatedJan 21, 2025
DataAggregated Company Financials
Companies210
- 7D0.3%
- 3M-6.0%
- 1Y1.2%
- YTD-0.6%
Over the last 7 days, the Healthcare industry has dropped 1.3%, driven by declines in Terumo and Takeda Pharmaceutical of 2.6% and 2.0%, respectively. Meanwhile, Daiichi Sankyo Company actually outperformed within the industry, gaining 6.9% in the last week. As for the longer term, the industry's performance has been flat for the past year. As for the next few years, earnings are expected to grow by 11% per annum.
Sector Valuation and Performance
Has the Japanese Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 21 Jan 2025 | JP¥65.8t | JP¥36.7t | JP¥2.2t | 16.6x | 29.4x | 1.8x |
| Thu, 19 Dec 2024 | JP¥66.6t | JP¥36.7t | JP¥2.2t | 16.2x | 29.7x | 1.8x |
| Sat, 16 Nov 2024 | JP¥69.2t | JP¥36.7t | JP¥2.2t | 16.8x | 30.8x | 1.9x |
| Mon, 14 Oct 2024 | JP¥71.5t | JP¥36.0t | JP¥2.0t | 17.6x | 36x | 2x |
| Wed, 11 Sep 2024 | JP¥69.1t | JP¥36.0t | JP¥2.0t | 17.3x | 34.8x | 1.9x |
| Fri, 09 Aug 2024 | JP¥66.5t | JP¥35.8t | JP¥2.0t | 16x | 34x | 1.9x |
| Sun, 07 Jul 2024 | JP¥68.7t | JP¥35.1t | JP¥1.8t | 17.9x | 37.2x | 2x |
| Tue, 04 Jun 2024 | JP¥65.4t | JP¥35.3t | JP¥1.9t | 17.7x | 35x | 1.9x |
| Thu, 02 May 2024 | JP¥65.0t | JP¥34.9t | JP¥2.0t | 17.3x | 32.6x | 1.9x |
| Sat, 30 Mar 2024 | JP¥66.9t | JP¥35.1t | JP¥2.0t | 18.4x | 34.1x | 1.9x |
| Mon, 26 Feb 2024 | JP¥67.2t | JP¥35.1t | JP¥2.0t | 18.7x | 34.3x | 1.9x |
| Wed, 24 Jan 2024 | JP¥67.1t | JP¥35.0t | JP¥2.2t | 18.8x | 31.1x | 1.9x |
| Fri, 22 Dec 2023 | JP¥61.8t | JP¥35.0t | JP¥2.2t | 18.1x | 28.7x | 1.8x |
| Sun, 19 Nov 2023 | JP¥63.1t | JP¥35.0t | JP¥2.2t | 17.3x | 29.3x | 1.8x |
| Tue, 17 Oct 2023 | JP¥62.3t | JP¥34.5t | JP¥2.3t | 17.6x | 27.4x | 1.8x |
| Thu, 14 Sep 2023 | JP¥64.7t | JP¥34.5t | JP¥2.3t | 17.9x | 28.5x | 1.9x |
| Sat, 12 Aug 2023 | JP¥64.6t | JP¥34.5t | JP¥2.3t | 18.9x | 28.6x | 1.9x |
| Mon, 10 Jul 2023 | JP¥62.8t | JP¥33.9t | JP¥2.3t | 18.1x | 27.1x | 1.9x |
| Wed, 07 Jun 2023 | JP¥67.1t | JP¥33.9t | JP¥2.3t | 18.4x | 29x | 2x |
| Fri, 05 May 2023 | JP¥62.9t | JP¥33.7t | JP¥2.3t | 17.8x | 27.9x | 1.9x |
| Sun, 02 Apr 2023 | JP¥60.3t | JP¥33.5t | JP¥2.3t | 16.8x | 26.2x | 1.8x |
| Tue, 28 Feb 2023 | JP¥58.9t | JP¥33.5t | JP¥2.3t | 16.7x | 25.6x | 1.8x |
| Thu, 26 Jan 2023 | JP¥60.6t | JP¥32.4t | JP¥2.2t | 16.2x | 27.9x | 1.9x |
| Sat, 24 Dec 2022 | JP¥60.4t | JP¥32.4t | JP¥2.2t | 15.9x | 27.8x | 1.9x |
| Mon, 21 Nov 2022 | JP¥64.1t | JP¥32.4t | JP¥2.2t | 15.8x | 29.4x | 2x |
| Wed, 19 Oct 2022 | JP¥63.9t | JP¥31.7t | JP¥2.3t | 15.7x | 28.3x | 2x |
| Fri, 16 Sep 2022 | JP¥62.5t | JP¥31.7t | JP¥2.3t | 15.9x | 27.7x | 2x |
| Sun, 14 Aug 2022 | JP¥62.6t | JP¥31.7t | JP¥2.3t | 16x | 27.7x | 2x |
| Tue, 12 Jul 2022 | JP¥61.6t | JP¥31.3t | JP¥2.3t | 16.2x | 26.7x | 2x |
| Thu, 09 Jun 2022 | JP¥57.9t | JP¥31.5t | JP¥2.3t | 15.7x | 25.3x | 1.8x |
| Sat, 07 May 2022 | JP¥59.1t | JP¥31.0t | JP¥2.5t | 16.8x | 24.1x | 1.9x |
| Mon, 04 Apr 2022 | JP¥58.3t | JP¥30.7t | JP¥2.4t | 17.2x | 24.4x | 1.9x |
| Wed, 02 Mar 2022 | JP¥58.7t | JP¥30.7t | JP¥2.4t | 16.6x | 24.5x | 1.9x |
| Fri, 28 Jan 2022 | JP¥55.7t | JP¥30.3t | JP¥2.4t | 16.1x | 23x | 1.8x |
Price to Earnings Ratio
23x
Current Industry PE
- Investors are relatively neutral on the Japanese Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 29.2x.
- The industry is trading close to its 3-year average PS ratio of 1.9x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 2.6% per year over the last three years.
- Meanwhile revenues for these companies have grown 6.7% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare sector?
| JP Market | -0.21% | |
| Healthcare | 0.30% | |
| Medical Equipment | 0.54% | |
| Pharma | 0.34% | |
| Healthtech | 0.24% | |
| Healthcare Services | 0.084% | |
| Biotech | -3.87% | |
| Life Sciences | -4.02% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 47.3x.
- Analysts are expecting annual earnings growth of 16.2%, which is higher than its past year's earnings decline of 11.1% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 16% over the next 5 years.
- This is better than its past earnings decline of 11% per year.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 8.5% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4568 Daiichi Sankyo Company | JP¥4.42k | 6.9% +JP¥539.3b | 0.6% | PE33.1x | |
| 7741 HOYA | JP¥21.02k | 3.0% +JP¥214.6b | 13.0% | PE37.1x | |
| 4483 JMDC | JP¥4.08k | 10.3% +JP¥24.8b | 1.2% | PE64.4x | |
| 6869 Sysmex | JP¥2.93k | 0.6% +JP¥10.9b | 5.1% | PE34.2x | |
| 7476 AS ONE | JP¥2.47k | 5.5% +JP¥9.3b | -10.5% | PE22.8x |
